- Education, Training & Outreach
- Patients & Caregivers
- For Investigators
- Dementia in the News
- Media Room
The Selective Muscarinic M1 Agonist AF102B Decreases Levels of Total ABeta in Cerebrospinal Fluid of Patients with Alzheimer’s Disease
Nitsch RM, Deng M, Tennis M, Schoenfeld D and Growdon JH (2000). The selective muscarinic m1 agonist af102b decreases levels of total abeta in cerebrospinal fluid of patients with alzheimer’s disease. Ann Neurol; 48: 913-918.